In this study, we investigate the relationship between RA-induced TG2 expression in an MCF-7 breast cancer cell line and sensitivity to cisplatin, observing that while increased TG2-L expression is strongly associated with the increased survival of cisplatin treatment, the silencing of TG2 increases cisplatin sensitivity significantly. The gene discussed is TGM2; the disease is breast carcinoma.